Virtual Reality-Based Transitional Care for ICU Survivors
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorMackay Memorial Hospital
About this trial
This study aims to evaluate the effectiveness of a virtual reality (VR)-based transitional care program for adult survivors of intensive care unit (ICU) care. ICU survivors frequently experience relocation stress, anxiety, pain, and physiological instability after transfer from the ICU to general wards, which may increase the risk of unplanned ICU readmission.
Participants will be randomly assigned to receive either standard transitional care or additional VR-based intervention sessions during their ICU stay. The VR intervention is designed to provide psychological support, environmental orientation, and stress reduction.
Primary outcomes include short-term physiological indicators within 48 hours after ICU transfer. Secondary outcomes include pain, relocation stress, and unplanned ICU readmission within 7 days.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 20 years or older
Adult patients admitted to the intensive care unit (ICU)
Planned transfer from ICU to the general ward
Able to communicate and provide informed consent or have a legal representative provide consent
Disqualifiers
Severe cognitive impairment or delirium preventing participation
Severe visual or hearing impairment interfering with VR use
Hemodynamic instability requiring immediate life-saving intervention
Isolation precautions prohibiting device use
Trial design
Design model
Parallel
Treatments tested in this trial
Virtual Reality-Based Transitional Care
BehavioralParticipants assigned to this arm will receive three structured virtual reality (VR) sessions during their ICU stay in addition to standard transitional care. Each VR session is designed to provide environmental orientation, psychological support, and stress reduction through immersive audiovisual content. The intervention aims to improve short-term physiological stability and reduce relocation stress following ICU transfer.
Treatment groups
150 Participants
are divided into 2 treatment groupsGroup A: VR Intervention GroupExperimental treatment 1 intervention
Group B: Standard Care GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Heart Rate Variability - RMSSD
Heart rate variability measured using the Root Mean Square of Successive Differences (RMSSD) derived from electrocardiographic recordings.
Time frame
Within 48 hours after transfer from the ICU to the general ward2
Heart Rate Variability - High Frequency Power
Heart rate variability measured using high-frequency (HF) power derived from electrocardiographic recordings.
Time frame
Within 48 hours after transfer from the ICU to the general wardSecondary outcomes
1
Pain Intensity
Pain intensity will be assessed using the Defense and Veterans Pain Rating Scale (DVPRS), a numeric rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst possible pain.
Time frame
Within 48 hours after ICU transfer2
Unplanned ICU Readmission
Occurrence of unplanned readmission to the ICU within 7 days after transfer to the general ward.
Time frame
Within 7 days after ICU transfer3
Relocation Stress
Relocation stress will be assessed using the Relocation Stress Syndrome Scale - Short Form (RSSS-SF). The scale consists of items rated on a Likert scale, with higher scores indicating greater relocation stress.
Time frame
Within 48 hours after ICU transferSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: